DA
BCAB

Denali Advisors’s BIOATLA INC BCAB Stock Holding History

Denali Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-146
Closed -$21.9K – 475
2023
Q2 		$21.9K Hold
146
– – 0.01% 335
2023
Q1 		$19.6K Hold
146
– – 0.01% 298
2022
Q4 		$60.2K Hold
146
– – 0.03% 205
2022
Q3 		$56K Buy
+146
New +$47.8K 0.03% 200

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Denali Advisors's BCAB Position: Q3 2023 in Review

Denali Advisors sold out of BIOATLA INC (BCAB) in Q3 2023, closing a stake of 146 shares — an estimated $21.9K sold.

Denali Advisors first reported a position in BCAB in Q3 2022 and held it in 4 quarters. The position peaked at $60.2K in Q4 2022. 82 funds tracked by Wall St. Rank hold BCAB as of Q3 2023.

  • Denali Advisors reported no remaining BIOATLA INC position as of Q3 2023 after selling out during the quarter.
  • Denali Advisors sold 146 BIOATLA INC shares in Q3 2023, an estimated $21.9K.
  • Denali Advisors first reported a position in BIOATLA INC in Q3 2022 and held it in 4 quarters.
  • Denali Advisors's BIOATLA INC position peaked at $60.2K in Q4 2022.
  • 82 funds tracked by Wall St. Rank held BIOATLA INC as of Q3 2023.

Based on Denali Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.